期刊文献+

超敏C反应蛋白测定在恶性肿瘤诊断中的意义 被引量:18

Significance of serum high sensitivity C-reactive protein in the diagnoses of malignant tumor
下载PDF
导出
摘要 目的探讨超敏C反应蛋白(highsensitivityC-reactiveprotein,hs-CRP)在恶性肿瘤诊断中的临床应用价值。方法应用免疫速率散射比浊法测定治疗前的253例恶性肿瘤、99例良性肿瘤、92例炎性包块患者及200例健康人血清hs-CRP水平。结果恶性肿瘤组及炎性包块组的血清hs-CRP明显高于良性肿瘤组和正常对照组(P<0.01),且炎性包块组的血清hs-CRP水平高于恶性肿瘤组(P<0.01),而良性肿瘤组hs-CRP与正常对照组比较无统计学意义(P>0.05)。结论在排除感染、创伤等引起CRP升高的情况下,患者血清hs-CRP升高要考虑恶性肿瘤的可能,CRP在恶性肿瘤诊断及病情评估上具有一定的临床意义。 [Objective] To explore the significanc of serum hs-CRP in patients with malignant tumor. [Methods] Serum hs-CRP in 253 patients with malignant tumor, 99 patients with benign tumor, 92 patients with inflammatory mass and 200 healthy people were evaluated by turbidimetric method based on the peak rate principle. [Resuits] The level of serum hs-CRP in patients with inflammatory mass or malignant tumor were significantly higher than that in patients with benign tumor or normal control (P 〈0,01), and hs-CRP in inflammatory mass group was higher than that in malignant tumor (P 〈0.01). There was no difference between benign tumor group and normal control (P 〉0.05). [Conclusion] The elevation of serum hs-CRP suggests the possibility of malignant tumor when inflammation, trauma and other disease which can cause the elevation of CRP, It's useful in the diagnosis and progression of malignant tumor.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第16期2523-2525,共3页 China Journal of Modern Medicine
基金 山东省卫生厅资助项目(HW100)
关键词 超敏C反应蛋白 肿瘤 炎症 high sensitivity C-reactive protein tumor inflammation
  • 相关文献

参考文献8

  • 1GELIN J,MOLDAWER LL,LONNROCH C,et al.Role of endogenous tumor necrosis factor alpha and interleukin-1 for experimental tumor growth and the development of cancer cachexia[J].Cancer Res,1991,51:415-421.
  • 2AZIZ N,FAHEY JL,DETELS R,et al.Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood[J].Clin Diagn Lab Immunol,2003,10:652-657.
  • 3NOZOE T,MATSUMATA T,KITAMURA M,et al.Significance of preoperative elevation of serum C-reactive protein as an indication for prognosis in colorectal cancer[J].Am J Surg,1998,176 (4):335-338.
  • 4YOSHIDA N,IKEMOTO S,NARITA K,et al.Interleukin-6,tumor necrosis factor alpha,and interleukin-1beta in patients with renal cell carcinoma[J].Br J Cancer,2002,86:1396-1400.
  • 5KOJI HASHIMOTO,YASUHARU IKEDA,DAISUKE KORENAGA,et al.The impact of preperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma[J].Am Cancer Society,2005,103(9):1856-1864.
  • 6TADAHIRO NOZOE,HIROSHI SAEKI,KEIZO SUGIMACHI.Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma[J].Am J Surg,2001,182:197-201.
  • 7NAKANISHI H,ARAKI N,KUDAWARA I,et al.Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma[J].Int J Cancer,2002,99:167-170.
  • 8余剑英,杨喜春.化学发光免疫法检测血清CEA,CA199和CA125水平在恶性肿瘤诊断中的意义(英文)[J].中国现代医学杂志,2004,14(16):21-23. 被引量:12

二级参考文献8

  • 1Roulston JE, Leonard RCE. Serological tumor markers Churchill Livingstone[M]. Black well scioxford, 1993: 11.
  • 2Haglunde Lundin J, Kunsela D, et al. CA242 a new tumor markers for Pancreatic cancer[J]. Br J cancer, 1994, 70: 487.
  • 3Pittaway DE. CA125 in women with emdometriosis[J]. Obstet Gynecol Clin North Am, 1989, 16(1): 237-252.
  • 4Sun WH, Serum CA125, the CA242 monitors the malignant tumor the illness, 1989, 16(1): 237-252.
  • 5Michael J, Conor J, Zauber A, Gottlieb LS, Winawer SJ, Precursors of colorectal carcinoma[J]. Cancer, 1992, 70(5): 1317-1327.
  • 6Favero GD, Fabris C, Plebani M, Panucci A, Piccoli A, Perobelli L et al. Ca199 and carcinoe mbryonic antigen inpancreatin cancer diagnosis[J]. Cancer, 1986, 57(8): 1576-1579.
  • 7YAO H, LIN ME, Serum CA125, CA199, CA50 levels to the diagnosis value to digestive system malignant tumor [J]. Shijie Huaren Xaiohua Zazhi, 1998, 6: 12. Chinese
  • 8HU M, YINL, WEI YJ. CEA, 17-1A of Related colorectal cancer immunity treatment[J]. Zhongguo Xiandai Yixue Zazhi, 2002,12(8): 6-4. Chinese

共引文献11

同被引文献113

引证文献18

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部